Serenex - Ownership and Business Overview

Life ScienceCompany

Serenex Ownership

Who owns Serenex?

Serenex is owned by Pfizer. It was acquired on March 3, 2008.

Serenex Business Overview

Where is Serenex headquartered?

Serenex is headquartered in Durham, North Carolina.

What sector is Serenex in?

Serenex is a life science company.

When was Serenex founded?

Serenex was founded in 2000.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

Serenex, Inc.

323 Foster Street,
Durham, North Carolina 27701
United States,
(919) 281-6001
www.serenex.com

Serenex, Inc., is a proteomics based drug discovery company. Develops proprietary human therapeutics that have improved likelihoods of clinical and economic success.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.